WHO official on mistakes made during pandemic; first Covid booster for teens cleared

"The biggest collective failing has been that we've underestimated this microbe," the WHO's Mike Ryan says of SARS-CoV-2.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      A WHO official weighs in on Covid, vaccines, and mistakes that were made By Helen Branswell FABRICE COFFRINI/AFP via Getty Images Mike Ryan, head of the health emergencies program at the World Health Organization, spoke in a wide-ranging interview with STAT. Read More STAT+: The biotech scorecard for the first quarter: 19 stock-moving events to watch By Adam Feuerstein Ryan Pierse/Getty Images Get ready for readouts on Abbvie's cystic fibrosis treatment, Gilead's newly acquired cancer drug Trodelvy, and much more. Read More FDA authorizes first Covid-19 booster shot for teens aged 12 to 15 By Helen Branswell FADEL SENNA/AFP via Getty Images A panel of independent experts that advises the CDC on vaccination policy is expected to discuss the policy change. Read More Sponsor content by GSK Navigating the impact of Covid-19 on oncology clinical trials In the midst of pandemic lockdown restrictions, patients faced severely limited access to timely medical care, resulting in a drastic reduction in cancer diagnoses. As resources were reallocated, clinical trials studying cancer treatments declined by 60% globally compared to pre-pandemic numbers, while nearly 80% of non-Covid trials were delayed or suspended altogether. Learn how a pharmaceutical company ensured the continuation of its clinical trials, none of which were suspended or delayed due to Covid-19. What racism in medicine takes from us By Jennifer Adaeze Okwerekwu Mike Reddy for STAT As a doctor, both what I know and how I have come to know it have continued to be shaped by the privileging of white norms and experiences. Read More STAT+: HHS appeals rulings over drug discount program just as AbbVie is latest to cut discounts By Ed Silverman Alex Hogan/STAT AbbVie insisted its plan to end discounts for some drugs on Feb. 1 will not disrupt supplies so long as patient claims data is provided. Read More Monday, January 3, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser